about
Trafficking GRK2: Cellular and Metabolic consequences of GRK2 subcellular localizationThe regulation of M1 muscarinic acetylcholine receptor desensitization by synaptic activity in cultured hippocampal neuronsG protein-coupled receptor kinase 2 and arrestin2 regulate arterial smooth muscle P2Y-purinoceptor signallingGRK3 suppresses L-DOPA-induced dyskinesia in the rat model of Parkinson's disease via its RGS homology domainTranscriptional profiling of laser capture microdissected rat arterial elements: fenoldopam-induced vascular toxicity as a model system.G protein-coupled receptor kinase-2 constitutively regulates D2 dopamine receptor expression and signaling independently of receptor phosphorylation.Regulation of oxytocin receptor responsiveness by G protein-coupled receptor kinase 6 in human myometrial smooth muscleSelective regulation of H1 histamine receptor signaling by G protein-coupled receptor kinase 2 in uterine smooth muscle cells.Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor.Arrestins differentially regulate histamine- and oxytocin-evoked phospholipase C and mitogen-activated protein kinase signalling in myometrial cells.Agonist-selective mechanisms of GPCR desensitizationCharacterization of the endocannabinoid system, CB(1) receptor signalling and desensitization in human myometrium.Arrestins 2 and 3 differentially regulate ETA and P2Y2 receptor-mediated cell signaling and migration in arterial smooth muscle.Defining the roles of arrestin2 and arrestin3 in vasoconstrictor receptor desensitization in hypertension.Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain.G protein-coupled receptor kinase 6 acts as a critical regulator of cytokine-induced hyperalgesia by promoting phosphatidylinositol 3-kinase and inhibiting p38 signaling.GRK2: putting the brakes on the circadian clock.The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alphaAltered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment.Combined integrin phosphoproteomic analyses and small interfering RNA--based functional screening identify key regulators for cancer cell adhesion and migration.Rich tapestry of G protein-coupled receptor signaling and regulatory mechanisms.Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulationGRK3 is essential for metastatic cells and promotes prostate tumor progression.The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease.Multiple functions of G protein-coupled receptor kinasesDual role of GRK5 in cancer development and progression.G protein-coupled receptor kinase 2-mediated phosphorylation of downstream regulatory element antagonist modulator regulates membrane trafficking of Kv4.2 potassium channel.Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2.Desensitization and internalization of endothelin receptor A: impact of G protein-coupled receptor kinase 2 (GRK2)-mediated phosphorylation.G protein-coupled receptor kinase 2 negatively regulates chemokine signaling at a level downstream from G protein subunitsRole of Phosphorylation in the Control of Clathrin-Mediated Internalization of GPCR.Negative regulation of VEGF signaling in human coronary artery endothelial cells by G protein-coupled receptor kinase 5GRK5 functions as an oncogenic factor in non-small-cell lung cancer.The Role of G Protein-coupled Receptor Kinases in Cancer.SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors.Suppressed G-protein-coupled receptor kinase 2 activity protects female diabetic-mouse aorta against endothelial dysfunction.G-protein-coupled receptor kinases in cardiovascular conditions: focus on G-protein-coupled receptor kinase 2, a gain in translational medicine
P2860
Q26865721-7ADF97CD-FBFD-4277-B8AD-9B20CD9DE1D6Q28577190-341DB066-AFF2-44A2-ACF3-FC7726A32BE8Q28578948-D0B8578B-D965-409B-87A3-F5A2F673E22DQ30653115-D761AA42-F1A7-4102-8D42-AC2C2C8F8659Q33333242-4B578890-BAA7-47FC-B9F8-81AD810D3EE8Q33553460-6935B283-2A29-45C2-9129-0F797379219CQ33642196-7FAB9D86-5768-4FB7-BA37-91A41792CF06Q33642724-2B3EFCA9-0A1F-43EB-95FA-507A92F36BCBQ33819496-3330BF09-DF59-4DF8-9B8B-81DCC70DCB77Q34672108-843CB24C-387F-4C37-8CEE-BEDF6B5A2F33Q34722029-E6F77B9E-E8D6-424F-9D94-3C9E664BFDA2Q35564284-62F291CC-C3C3-4AA4-B92E-5855D1FB7A42Q35849415-275EE472-5747-44E8-8A0C-527052DFE3A4Q35916711-48CD17A5-35DF-4FB2-8877-9BA21E71D05FQ36038255-37E11811-BA82-42BA-94DF-A560E87AC91DQ36071756-81718B69-15F0-4217-9466-026539CCB1EDQ36795417-230E3C6D-527E-46C8-A22B-16454B24FC14Q36976809-80EFEE5F-A708-4E20-94B3-7905DBE636B1Q37067437-1D3F9C30-708A-4D3D-9E90-80965F964120Q37160317-2FF1B854-DA24-4DBF-85F2-C9690F312206Q37178682-19F52E08-7F55-4CE9-988F-570AB875F1A9Q37416728-B0F630A6-90AD-4A96-B7A6-8FD34319219FQ37543846-26777074-1F54-483D-870F-575A56800E28Q37702799-8FC431A2-3875-4F76-826C-693F41D80442Q38599397-7A3F8BDC-BB0F-4A2A-AF15-ED3B1CB6C229Q38871791-0EFAB804-7B6B-47B7-80D2-354EB6DE65B6Q40208895-DDDAC1F4-5E40-4808-8314-E40E811A349BQ41906789-5B0C7A59-56F3-46A2-AABD-D4F6784E71CEQ41991082-FB32CEE0-2C59-436F-A073-41DC8258DD79Q42104261-1F3C058A-B2CB-4E0D-B4C3-81CA4501C432Q42148785-A0BAB7F6-8029-48A2-8746-76A854A0BD3CQ42316399-655005B3-275F-415D-BD02-83581208C6B9Q49789981-7276EBE0-3ABB-4132-9431-60D2A4D98E57Q50285621-6B35813D-F76D-461A-97EA-7DC829A16641Q50939912-C5B5B1C7-E010-4641-A1F4-FEE8FD1B9031Q51315493-AC886BEE-E89C-43D0-AF1A-EE838DDAE7F9Q58651692-37D1669C-35A7-4EDB-836C-BA7D31A8E9BD
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Non-visual GRKs: are we seeing the whole picture?
@ast
Non-visual GRKs: are we seeing the whole picture?
@en
Non-visual GRKs: are we seeing the whole picture?
@nl
type
label
Non-visual GRKs: are we seeing the whole picture?
@ast
Non-visual GRKs: are we seeing the whole picture?
@en
Non-visual GRKs: are we seeing the whole picture?
@nl
prefLabel
Non-visual GRKs: are we seeing the whole picture?
@ast
Non-visual GRKs: are we seeing the whole picture?
@en
Non-visual GRKs: are we seeing the whole picture?
@nl
P2093
P1476
Non-visual GRKs: are we seeing the whole picture?
@en
P2093
Jonathon M Willets
R A John Challiss
Stefan R Nahorski
P304
P356
10.1016/J.TIPS.2003.10.003
P407
P577
2003-12-01T00:00:00Z